Edgestream Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $946K | Sell |
1,029
-2,867
| -74% | -$2.91M | 0.03% | 644 |
|
|
2025
Q4 | $4.19M | Sell |
3,896
-2,283
| -37% | -$2.18M | 0.12% | 310 |
|
|
2025
Q3 | $4.71M | Buy |
6,179
+4,165
| +207% | +$3.1M | 0.14% | 265 |
|
|
2025
Q2 | $1.57M | Sell |
2,014
-5,771
| -74% | -$4.48M | 0.04% | 572 |
|
|
2025
Q1 | $6.43M | Buy |
7,785
+3,805
| +96% | +$3.17M | 0.22% | 158 |
|
|
2024
Q4 | $3.07M | Sell |
3,980
-4,364
| -52% | -$3.61M | 0.13% | 305 |
|
|
2024
Q3 | $7.39M | Sell |
8,344
-5,043
| -38% | -$4.53M | 0.33% | 45 |
|
|
2024
Q2 | $12.1M | Buy |
13,387
+8,039
| +150% | +$6.43M | 0.58% | 7 |
|
|
2024
Q1 | $4.16M | Buy |
5,348
+649
| +14% | +$462K | 0.21% | 158 |
|
|
2023
Q4 | $2.74M | Buy |
4,699
+2,434
| +107% | +$1.42M | 0.2% | 163 |
|
|
2023
Q3 | $1.22M | Sell |
2,265
-9,361
| -81% | -$4.82M | 0.1% | 340 |
|
|
2023
Q2 | $5.45M | Buy |
11,626
+1,226
| +12% | +$514K | 0.49% | 12 |
|
|
2023
Q1 | $3.57M | Buy |
10,400
+4,988
| +92% | +$1.68M | 0.39% | 47 |
|
|
2022
Q4 | $1.98M | Buy |
5,412
+2,024
| +60% | +$718K | 0.22% | 149 |
|
|
2022
Q3 | $1.1M | Sell |
3,388
-18,571
| -85% | -$5.88M | 0.08% | 263 |
|
|
2022
Q2 | $7.12M | Sell |
21,959
-2,527
| -10% | -$759K | 0.56% | 31 |
|
|
2022
Q1 | $7.01M | Buy |
24,486
+19,588
| +400% | +$5.04M | 0.56% | 27 |
|
|
2021
Q4 | $1.35M | Sell |
4,898
-39,692
| -89% | -$10.1M | 0.08% | 275 |
|
|
2021
Q3 | $10.3M | Sell |
44,590
-3,191
| -7% | -$788K | 0.64% | 33 |
|
|
2021
Q2 | $11M | Buy |
47,781
+38,536
| +417% | +$7.74M | 0.65% | 32 |
|
|
2021
Q1 | $1.73M | Buy |
+9,245
| New | +$1.81M | 0.1% | 256 |
|
|
2020
Q4 | – | Sell |
-2,327
| Closed | -$344K | – | 398 |
|
|
2020
Q3 | $344K | Buy |
+2,327
| New | +$360K | 0.02% | 264 |
|
|
2019
Q4 | – | Sell |
-39,224
| Closed | -$4.39M | – | 339 |
|
|
2019
Q3 | $4.39M | Sell |
39,224
-126,674
| -76% | -$14.1M | 0.42% | 81 |
|
|
2019
Q2 | $18.4M | Buy |
165,898
+96,684
| +140% | +$11.4M | 2.07% | 5 |
|
|
2019
Q1 | $8.98M | Buy |
+69,214
| New | +$8.42M | 1.32% | 17 |
|
|
2018
Q1 | – | Sell |
-2,539
| Closed | -$214K | – | 258 |
|
|
2017
Q4 | $214K | Sell |
2,539
-1,902
| -43% | -$162K | 0.26% | 78 |
|
|
2017
Q3 | $380K | Sell |
4,441
-13,582
| -75% | -$1.11M | 0.2% | 84 |
|
|
2017
Q2 | $1.48M | Sell |
18,023
-2,284
| -11% | -$186K | 0.56% | 41 |
|
|
2017
Q1 | $1.71M | Buy |
+20,307
| New | +$1.63M | 0.75% | 26 |
|
|
2016
Q4 | – | Sell |
-10,057
| Closed | -$807K | – | 115 |
|
|
2016
Q3 | $807K | Buy |
+10,057
| New | +$805K | 0.44% | 52 |
|
Other funds holding LLY
VCM
VPM
Edgestream Partners's LLY Position: Q1 2026 in Review
Edgestream Partners reduced its Eli Lilly (LLY) stake by 74% in Q1 2026, selling an estimated $2.91M and leaving 1,029 shares worth $946K. The position accounts for 0.03% of the portfolio, ranked #644.
Edgestream Partners first reported a position in LLY in Q3 2016 and has held it in 30 quarters since. The position peaked at $18.4M in Q2 2019. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Edgestream Partners held 1,029 shares of Eli Lilly worth $946K as of Q1 2026.
- Edgestream Partners sold 2,867 Eli Lilly shares in Q1 2026, an estimated $2.91M.
- Eli Lilly made up 0.03% of Edgestream Partners's portfolio in Q1 2026, its #644 holding.
- Edgestream Partners first reported a position in Eli Lilly in Q3 2016 and has held it in 30 quarters since.
- Edgestream Partners's Eli Lilly position peaked at $18.4M in Q2 2019.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.